[Treatment of patients with destructive pulmonary tuberculosis with concomitant diabetes mellitus].
Diabetes mellitus accompanying tuberculosis complicates the course of the latter and remains a topical problem of phthisiology. Surgical treatment of patient with both conditions presents a high risk and is employed unreasonably rarely. The results of medical (173 patients) and surgical (107 patients) treatments were studied in patients with destructive tuberculosis concurrent with diabetes mellitus. Analyzing early and late results of treatment showed a more steady-state effect in the group of surgically treated patients. Thus, surgery should be desirably used in all patients with preserving destructive changes after the basic course of antibacterial therapy.
Giller
D B
DB
Kostenko
A D
AD
Giller
B M
BM
Giller
G V
GV
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D048909:Diabetes Complications; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011013:Pneumonectomy; D012293:Rifampin / Q000627:therapeutic use; D012307:Risk Factors; D013905:Thoracoplasty; D013997:Time Factors; D014375:Tuberculoma / Q000150:complications / Q000601:surgery / Q000628:therapy; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D007538:Isoniazid; D012293:Rifampin